Fact CheckerSign in

NCT05755451Recruiting

Natural History of SMA

Natural History of SMA: Long Term Longitudinal Study and Development of a Registry

Source: ClinicalTrials.gov · Last updated 6 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is an investigator initiated observational study with the aim to record several aspects of function, care and adverse events in a large cohort of SMA patients followed longitudinally by using a structured academic disease registry.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1200 (estimated)
First submitted
8 Feb 2023
Start date
21 Jun 2018
Primary completion date
30 Dec 2033
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT number
NCT05755451

What you commit to

  • Study type: Observational
  • Planned participants: 1200
  • From 21 Jun 2018 to the primary completion date, 30 Dec 2033
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • if enrolled in clinical trials

Who the study is looking for

  • all patients

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituto Gaslini
Coordinator of this site? Confirm its status
GenovaItalyRecruiting
Nemo Sud
Coordinator of this site? Confirm its status
MessinaItalyRecruiting
Centro Clinico Nemo
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Policlinico Gemelli
Coordinator of this site? Confirm its status
RomeItalyRecruiting
Ospedale Bambino gesu
Coordinator of this site? Confirm its status
RomeItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.